Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference78 articles.
1. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.;Acton;Science,1996
2. Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36.;Arenas;Hum. Pathol.,2004
3. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases.;Baranova;J. Biol. Chem.,2005
4. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins.;Calvo;Arterioscler. Thromb. Vasc. Biol.,1997
5. Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging.;Cao;Bioconjug. Chem.,2009
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Detection of atherosclerotic plaques with HDL-like porphyrin nanoparticles using an intravascular dual-modality optical coherence tomography and fluorescence system;Scientific Reports;2024-05-29
2. Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease;Cardiovascular Research;2024-05
3. Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting;Journal of Controlled Release;2024-04
4. Assessment of the diagnostic value of serum cathepsin S and its correlation with HDL subclasses in patients with non-Hodgkin's lymphoma;Journal of Medical Biochemistry;2024
5. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers;Advanced Drug Delivery Reviews;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3